Aspectos relevantes de ciencias básicas y clínicas sobre la toxoplasmosis. Especial énfasis en la toxoplasmosis congénita
Contenido principal del artículo
Resumen
Descargas
Detalles del artículo
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
No se permite un uso comercial de la obra original ni de las posibles obras derivadas, la distribución de las cuales se debe hacer con una licencia igual a la que regula la obra original.
Citas
Frenkel JK. Biology of Toxoplasma gondii. Congenital toxoplasmosis. Paris: Springer; 2000.
Zhang Y, Lai BS, Juhas M, Zhang Y. Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis. Microbiol Res. 2019;227:126293. https://doi.org/10.1016/j.micres.2019.06.003
Flegr J, Prandota J, Sovičková M, Israili ZH. Toxoplasmosis - A Global Threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 2014;9:e90203. https://doi.org/10.1371/journal.pone.0090203
Juárez M, Martínez F, Rivera M, Pérez L, Castillo J, Sánchez R. Posibles factores de riesgo asociados a seropositividad y seronegatividad de IgM para toxoplasmosis en Tamaulipas [Potential risk factors associated with IgM seropositivity and seronegativity for toxoplasmosis in Tamaulipas]. JONNPR. 2021;6:1446-60. https://doi.org/10.19230/jonnpr.4504
Cifuentes-González C, Rojas-Carabali W, Pérez ÁO, Carvalho É, Valenzuela F, Miguel-Escuder L, et al. Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis. PLoS One. 2023;18:e0283845. https://doi.org/10.1371/journal.pone.0283845
Cruz-Quevedo M, Hernández-Cruz A, Dorta-Contreras AJ. El nexo entre biología, respuesta inmune y clínica en la infección por Toxoplasma gondii [The biology-immune response-clinical nexus in Toxoplasma gondii infection]. Rev Cuba Investig Biomed. 2019;38:1-23.
Megli CJ, Coyne CB. Infections at the maternal-fetal interface: An overview of pathogenesis and defence. Nat Rev Microbiol. 2022;20:67-82. https://doi.org/10.1038/s41579-021-00610-y
Chung MH, Shin CO, Lee J. TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates: Efficacy study in a single institute in Korea. Korean J Pediatr. 2018;61:114. https://doi.org/10.3345/kjp.2018.61.4.114
Di Carlo P, Romano A, Casuccio A, Cillino S, Schimmenti MG, Mancuso G, et al. Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: A prospective study. Acta Pharmacol Sin. 2011;32:1063-70. https://doi.org/10.1038/aps.2011.55
Estévez-Reboredo R, de Fuentes-Corripio I, Carmona R, Cano-Portero R. Toxoplasmosis en España, análisis de las hospitalizaciones en el periodo 1997-2018 [Toxoplasmosis in Spain, analysis of hospitalizations in the period 1997-2018]. Rev Esp Salud Publica. 2021;95:1-11.
Grandia G R, Entrena G. Á, Cruz H. J. Toxoplasmosis en Felis catus: etiología, epidemiología y enfermedad [Toxoplasmosis in Felis catus: Etiology, epidemiology and disease]. Rev Investig Vet Peru. 2013;24:131-49.
Rueda YS, Valbuena L, Quintero N, Pinilla A, Sayago J. Toxoplasmosis congénita, una mirada en la actualidad del tratamiento; revisión de la literatura [Congenital toxoplasmosis, a look at current treatment; literature review]. MedUNAB. 2019;22:51-63. https://doi.org/10.29375/01237047.2612
Gómez JE. Guía de práctica clínica para toxoplasmosis durante el embarazo y toxoplasmosis congénita en Colombia [Clinical practice guidelines for toxoplasmosis during pregnancy and congenital toxoplasmosis in Colombia]. Infectio. 2007;11:129-41.
Campo-Portacio DM, Guerrero-Velásquez LF, Castillo-García AP, Orozco-Méndez K, Blanco-Tuirán PJ. Detección de Toxoplasma gondii en agua para el consumo humano proveniente de jagüeyes del área rural del municipio de Sincelejo [Detection of Toxoplasma gondii in water for human consumption from rural area of the municipality of Sincelejo]. Biomedica. 2021;41:82-99. https://doi.org/10.7705/biomedica.5858
Cedeño-Quevedo PASBMJSPAL. Toxoplasmosis en embarazadas en el centro de salud Puerto Bolívar perspectiva enfermería Machala-Ecuador [Toxoplasmosis in pregnant women at the Puerto Bolivar health center, Machala-Ecuador, Ecuador]. Polo del Conocimiento. 2023;8:1498-514.
Chávez-Arévalo MA, Roa-Correa ST, Terraza-Cadavid JA, García-Cuan A. Nivel de conocimiento sobre toxoplasmosis en mujeres gestantes que asisten a consulta prenatal [Level of knowledge about toxoplasmosis in pregnant women attending prenatal consultation]. Biociencias. 2022;17:15-24. https://doi.org/10.18041/2390-0512/biociencias.2.10690
Celis-Giraldo D, García López LL, Valencia Hernández JD, Acosta Dávila JA, Vargas Montes M, Gómez Marín JE. Conocimientos, actitudes y prácticas sobre toxoplasmosis en dos comunas de Armenia, Quindío, con alta prevalencia de la infección [Knowledge, attitudes and practices about toxoplasmosis in two communities of Armenia, Quindío, with high prevalence of infection]. Rev Fac Nac Salud Publica. 2021;40:e344576. https://doi.org/10.17533/udea.rfnsp.e344576
Mejía-Oquendo M, Marulanda-Ibarra E, Gómez-Marin JE. Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis. Lancet Regional Health - Americas. 2021;1:100010. https://doi.org/10.1016/j.lana.2021.100010
Gómez-Marín JE. Éxitos y retos para el control de la toxoplasmosis congénita en Colombia [Successes and challenges for the control of congenital toxoplasmosis in Colombia]. Infectio. 2023;24:222-8. https://doi.org/10.22354/24223794.1145
Andamayo Flores JL, Canchanya Valentin YR. Transmisión vertical de Toxoplasma gondii asociado a la edad gestacional [Vertical transmission of Toxoplasma gondii associated with gestational age]. Bol Malariol Salud Ambient. 2022;62:1219-26. https://doi.org/10.52808/bmsa.7e6.626.013
Robert Gangneux F, Murat JB, Fricker-Hidalgo H, Brenier Pinchart MP, Gangneux JP, Pelloux H. The placenta: ¿A main role in congenital toxoplasmosis? Trends Parasitol. 2011;27:530-6. https://doi.org/10.1016/j.pt.2011.09.005
Gras L, Wallon M, Pollak A, Cortina‐borja M, Evengard B, Hayde M, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centres. Acta Paediatr. 2005;94:1721-31. https://doi.org/10.1111/j.1651-2227.2005.tb01844.x
Jones EJ, Korcsmaros T, Carding SR. Mechanisms and pathways of Toxoplasma gondii transepithelial migration. Tissue Barriers. 2017;5:e1273865. https://doi.org/10.1080/21688370.2016.1273865
Faral-Tello P, Pagotto R, Bollati-Fogolín M, Francia ME. Modeling the human placental barrier to understand Toxoplasma gondii vertical transmission. Front Cell Infect Microbiol. 2023;13:1130901. https://doi.org/10.3389/fcimb.2023.1130901
Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007;369:115-22. https://doi.org/10.1016/S0140-6736(07)60072-5
Deshmukh AS, Gurupwar R, Mitra P, Aswale K, Shinde S, Chaudhari S. Toxoplasma gondii induces robust humoral immune response against cyst wall antigens in chronically infected animals and humans. Microb Pathog. 2021;152:104643. https://doi.org/10.1016/j.micpath.2020.104643
Rosso F, Agudelo A, ISAZA Á, Montoya JG. Toxoplasmosis congénita: aspectos clínicos y epidemiológicos de la infección durante el embarazo [Congenital toxoplasmosis: Clinical and epidemiological aspects of infection during pregnancy]. Colomb Med. 2007;38:316-37.
Alberto Cortesa J, Enrique Gómez J, Ignacio Silva P, Arévalo L, Arevalo Rodriguez I, Álvarez MI, et al. Guía de atención integral para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto y puerperio: sección toxoplasmosis en el embarazo [Comprehensive care guide for the prevention, early detection and treatment of complications of pregnancy, childbirth and puerperium: Toxoplasmosis in pregnancy section]. Infectio. 2017;21:102-16. http://dx.doi.org/10.22354/in.v21i2.654
Yang C, Mai H, Peng J, Zhou B, Hou J, Jiang D. STAT4: An immunoregulator contributing to diverse human diseases. Int J Biol Sci. 2020;16:1575-85. https://doi.org/10.7150/ijbs.41852
Smith JE, McNeil G, Zhang YW, Dutton S, Biswas-Hughes G, Appleford P. Serological recognition of Toxoplasma gondii cyst antigens. Toxoplasma gondii. Berlin: Springer; 1996.
Coto Freund F, Murillo Barquero F, Rocha Monge SM. Encefalitis por Toxoplasma gondii en pacientes con virus de la inmunodeficiencia humana [Toxoplasma gondii encephalitis in patients with human immunodeficiency virus]. Rev Med Sinergia. 2021;6:e723. https://doi.org/10.31434/rms.v6i10.723
Sardinha Silva A, Mendonça Natividade FC, Pinzan CF, Lopes CD, Costa DL, Jacot D, et al. The lectin-specific activity of Toxoplasma gondii microneme proteins 1 and 4 binds Toll-like receptor 2 and 4 N-glycans to regulate innate immune priming. PLoS Pathog. 2019;15:e1007871. https://doi.org/10.1371/journal.ppat.1007871
Selleck EM, Fentress SJ, Beatty WL, Degrandi D, Pfeffer K, Virgin HW, et al. Guanylate-binding protein 1 (Gbp1) Contributes to cell-autonomous immunity against Toxoplasma gondii. PLoS Pathog. 2013;9:e1003320. https://doi.org/10.1371/journal.ppat.1003320
Tretina K, Park ES, Maminska A, MacMicking JD. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. J Exp Med. 2019;216:482-500. https://doi.org/10.1084/jem.20182031
Rosowski EE, Nguyen QP, Camejo A, Spooner E, Saeij JPJ. Toxoplasma gondii inhibits gamma interferon (IFN-γ)- and IFN-β-Induced Host Cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA. Infect Immun. 2014;82:706-19. https://doi.org/10.1128/IAI.01291-13
Lu JM, Xu X, Aosai F, Zhang MY, Zhou LL, Piao LX. Protective effect of arctin against Toxoplasma gondii HSP70-induced allergic acute liver injury by disrupting the TLR4-mediated activation of cytosolic phospholipase A2 and platelet-activating factor. Int Immunopharmacol. 2024;126:111254. https://doi.org/10.1016/j.intimp.2023.111254
Egan CE, Sukhumavasi W, Butcher BA, Denkers EY. Functional aspects of Toll-like receptor/MyD88 signalling during protozoan infection: Focus on Toxoplasma gondii. Clin Exp Immunol. 2009;156:17-24. https://doi.org/10.1111/j.1365-2249.2009.03876.x
Pantoja Ruiz C, Martínez A, Ferreiros A, Millán S, Coral J. Toxoplasmosis en sistema nervioso central: revisión sobre la patología, abordaje diagnóstico y tratamiento [Toxoplasmosis in the central nervous system: Review of pathology, diagnostic approach and treatment]. Acta Neurol Colomb. 2021;37:141-7. https://doi.org/10.22379/24224022346
Lima TS, Gov L, Lodoen MB. Evasion of human neutrophil-mediated host defense during Toxoplasma gondii Infection. MBio. 2018;9:1. https://doi.org/10.1128/mBio.02027-17
Valero Cedeño NJ, Delgado Mendoza RF, Pérez Conforme HG, Jalca Toala AE. Toxoplasmosis en el embarazo: Importancia del diagnóstico temprano [Toxoplasmosis in Pregnancy: Importance of early diagnosis]. Pol Con. 2020;5:907-17.
Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol Rev. 2020;34:101128. https://doi.org/10.1128/CMR.00115-19
Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353:1829-33. https://doi.org/10.1016/S0140-6736(98)08220-8
Kaye A. Toxoplasmosis: Diagnosis, treatment, and prevention in congenitally exposed infants. J Pediatr Health Care. 2011;25:355-64. https://doi.org/10.1016/j.pedhc.2010.04.008
Tamma P. Toxoplasmosis. Pediatr Rev. 2007;28:470-1. https://doi.org/10.1542/pir.28.12.470
Tian C, Ali SA, Weitkamp JH. Congenital infections, Part I: Cytomegalovirus,toxoplasma, rubella, and herpes simplex. Neoreviews. 2010;11:e436-46. https://doi.org/10.1542/neo.11-8-e436
Giannoulis C, Zournatzi B, Giomisi A, Diza E, Tzafettas I. Toxoplasmosis during pregnancy: A case report and review of the literature. Hippokratia. 2008;12:139-43.
Dard C, Fricker Hidalgo H, Brenier Pinchart MP, Pelloux H. Relevance of and new developments in serology for toxoplasmosis. Trends Parasitol. 2016;32:492-506. https://doi.org/10.1016/j.pt.2016.04.001
Montoya JG. Systematic screening and treatment of toxoplasmosis during pregnancy: Is the glass half full or half empty? Am J Obstet Gynecol. 2018;219:315-9. https://doi.org/10.1016/j.ajog.2018.08.001
Foulon W. Congenital toxoplasmosis: Is screening desirable? Scand J Infect Dis Suppl. 1992; 84:11-7.
Vasconcelos Santos DV, Dodds EM, Oréfice F. Review for disease of the year: Differential diagnosis of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:171-9. https://doi.org/10.3109/09273948.2011.581407
Pomares C, Montoya JG. Laboratory diagnosis of congenital toxoplasmosis. J Clin Microbiol. 2016;54:2448-54. https://doi.org/10.1128/JCM.00487-16
Rorman E, Zamir C, Rilkis I, Bendavid H. Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol. 2006;21:458-72. https://doi.org/10.1016/j.reprotox.2005.10.006
Mandelbrot L, Kieffer F, Sitta R, Laurichesse Delmas H, Winer N, Mesnard L, et al. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: A multicenter, randomized trial. Am J Obstet Gynecol. 2018;219:386. https://doi.org/10.1016/j.ajog.2018.05.031
Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, et al. Congenital toxoplasmosis: The state of the art. Front Pediatr. 2022;10:1-12. https://doi.org/10.3389/fped.2022.894573
Montoya JG, Remington JS. Clinical Practice: Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554-66. https://doi.org/10.1086/590149
Peters PJ, Thigpen MC, Parise ME, Newman RD. Safety and toxicity of sulfadoxine/pyrimethamine. Drug Safety. 2007;30:481-501. https://doi.org/10.2165/00002018-200730060-00003
Ocaña-Arguello ND, Paredes-Cruz AP, Raysa-Astrid FA, Pazmiño-Álvarez EK. Toxoplasmosis congénita diagnóstico y tratamiento [Congenital toxoplasmosis diagnosis and treatment]. Recimundo. 2020;4:118-27.
De La Fuente-Villar BB, Neves E de S, Louro VC, Lessa JF, Rocha DN, Gomes LHF, et al. Toxoplasmosis in pregnancy: a clinical, diagnostic, and epidemiological study in a referral hospital in Rio de Janeiro, Brazil. Braz J Infect Dis. 2020;24:517-23. https://doi.org/10.1016/j.bjid.2020.10.001
Han L, Li R, Xiong W, Hu Y, Wu J, Liu X, et al. Prevalence of preconception TORCH infections and its influential factors: Evidence from over 2 million women with fertility desire in southern China. BMC Women's Health. 2023;23:425. https://doi.org/10.1186/s12905-023-02560-4
Robert MG, Brenier-Pinchart MP, Garnaud C, Fricker-Hidalgo H, Pelloux H. Molecular diagnosis of toxoplasmosis: Recent advances and a look to the future. Expert Rev Anti Infect Ther. 2021;19:1529-42. https://doi.org/10.1080/14787210.2021.1941867